Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimized a method for tumor diagnosis using radionuclides. Potential side-effects can now be significantly reduced through a molecular trick. The researchers report their results in the current issue of Bioorganic & Medicinal Chemistry.
Click here for original story, Making tumor diagnosis kinder to kidneys
Source: Phys.org